<DOC>
	<DOCNO>NCT01369823</DOCNO>
	<brief_summary>The purpose study examine whether pump treatment combine use continuous glucose monitoring system mena normalize glycaemic control .</brief_summary>
	<brief_title>Diabetes Multicenter Observational Study ( DIAMOND-1- )</brief_title>
	<detailed_description>In study , 100 subject , user Paradigm 522/722 Infusion Pump Self- Monitoring Blood Glucose finger stick control glucose level least 3 month prior enrollment participate . Moreover subject wo n't achieve best blood glucose control , average HbA1c 7 % meet inclusion none exclusion criterion . The HbA1c value screening purpose take medical chart , enrollment visit accord current medical practice investigational center , sample take HbA1c measurement analyze centrally HPLC , lab Germany . In enrolled patient continuous glucose monitoring system provide . Since observational study , provision glucose monitor system base medical justification do per protocol requirement . All subject follow 3 month accord current medical practice investigational center . All visit , e.g . patient come hospital symptom , also record unscheduled visit . These visit usually link Adverse Events .</detailed_description>
	<criteria>Subjects and/or legal representative must sign Patient Data Release Form ( PDRF ) . Subjects must age 12 45 year old . Subjects must pump Self Monitoring Blood Glucose fingersticks user least 3 month 9 month . HbA1c &gt; 7.0 % measurement old three month prior enrollment . Diagnosed T1D least 1 year study entry . Subjects must able understand use Paradigm REALTime System adjust administer corrective treatment . Subjects use sensor past . Hearing vision impairment alarm recognize . Alcohol drug abuse nicotine . Subjects suffer severe chronic disease genetic disorder T1D . ( i.e . Down syndrome etc . ) Subjects suffer allergy . Subjects pregnancy desire conceive study . Subjects participate device drug study .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>HbA1c</keyword>
	<keyword>Paradigm 522/722 Infusion Pump</keyword>
	<keyword>Transmitter ( MMT-7703WW )</keyword>
	<keyword>Sensor MMT-7002 ( i.e . Glucose Sensor )</keyword>
	<keyword>Levels HbA1c enrollment high 7</keyword>
</DOC>